Literature DB >> 1804648

Impact of clinical trials on the adoption of new drugs within a university hospital.

P Denig1, F M Haaijer-Ruskamp, H Wesseling, A Versluis.   

Abstract

To assess the influence that clinical trials may have on the introduction of new drugs into prescribing routines, the adoption of drugs has been studied in a university hospital in the Netherlands. A significant relation was found between the testing of semi-innovative drugs in clinical trials in the hospital and the introduction of these drugs into general use in the same hospital. No such relationship was found for innovative drugs. Employment in clinical trials only affected the frequency of adoption of semi-innovative drugs. It did not influence the quantity of their use once they had been adopted. The idea that the stimulating effect of clinical trials on the adoption of semi-innovative drugs is only due to acceleration of the adoption process was not confirmed. These findings support the idea that clinical trials can lower the barriers for adoption of semi-innovative drugs.

Mesh:

Substances:

Year:  1991        PMID: 1804648     DOI: 10.1007/BF00314961

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Does participation in clinical trials influence the costs of future management of patients?

Authors:  Anne Hvenegaard; Henrik Hauschildt Juhl; Andreas Habicht
Journal:  Eur J Health Econ       Date:  2011-11-10

2.  Diffusion of new medicines into hospital practice.

Authors:  J E F Zwart-van Rijkom; N S Breekveldt-Postma; H G M Leufkens; A C G Egberts
Journal:  Eur J Clin Pharmacol       Date:  2003-08-09       Impact factor: 2.953

3.  Explanatory model of prescribing behavior in prescription of statins in family practice.

Authors:  Ksenija Tusek-Bunc; Janko Kersnik; Marija Petek-Ster; Davorina Petek; Zalika Klemenc-Ketis
Journal:  Wien Klin Wochenschr       Date:  2010-05       Impact factor: 1.704

4.  Early National Dissemination of Abiraterone and Enzalutamide for Advanced Prostate Cancer in Medicare Part D.

Authors:  Megan E V Caram; Tudor Borza; Hye-Sung Min; Jennifer J Griggs; David C Miller; Brent K Hollenbeck; Bhramar Mukherjee; Ted A Skolarus
Journal:  J Oncol Pract       Date:  2017-06-19       Impact factor: 3.840

5.  Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series Analysis.

Authors:  Guillaume Butler-Laporte; Matthew P Cheng; Daniel J G Thirion; Samuel De L'Étoile-Morel; Charles Frenette; Katryn Paquette; Alexander Lawandi; Emily G McDonald; Todd C Lee
Journal:  Open Forum Infect Dis       Date:  2020-09-24       Impact factor: 3.835

6.  Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology.

Authors:  Nabarun Dasgupta; John R Brown; Maryalice Nocera; Allison Lazard; Svetla Slavova; Patricia R Freeman
Journal:  Pain Ther       Date:  2021-12-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.